ESC 365 - Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Open Access

Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies

Session: The right glucose-lowering drugs for the right patient

Topic: Epidemiology

Speaker: Doctor M. Malik (Copenhagen, DK)

Event: ESC CONGRESS 2019

Congress Session

About the speaker

Doctor Mariam Elmegaard Malik

Gentofte University Hospital, Copenhagen (Denmark)

0 follower

3 more presentations in this session

State of the Art in antidiabetic treatment to prevent CVD

Speaker: Professor A. Norhammar (Stockholm, SE)

Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study

Speaker: Mrs M. Fangel (Aalborg, DK)

Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus

Speaker: Doctor D. Berg (Boston, US)

Access the full session

The right glucose-lowering drugs for the right patient

Speakers: Doctor M. Malik, Professor A. Norhammar, Mrs M. Fangel, Doctor D. Berg

About the event

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

Congress

Related content

Open Access

Heart failure with preserved ejection fraction.

10 December 2021

Open Access

Mode of intervention in aortic stenosis.

28 August 2021

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

This platform is supported by